ORCID as entered in ROS
https://orcid.org/0000-0001-6142-3291
Select Publications
Conference Papers
, 2014, 'Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at
, 2014, 'CURRENT CLINICIAN PRACTICES IN UTILISING RADIOTHERAPY AND TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - A SURVEY OF AUSTRALIAN AND NEW ZEALAND CLINICIANS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 36 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Stereotactic body radiotherapy using 4D image-guidance for inoperable primary liver cancer or metastases', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S124 - S125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687118700358&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Hepatocyte Growth Factor (HGF) inhibition may be a superior therapeutic approach than gemcitabine in pancreatic cancer', Melbourne, presented at
, 2014, 'The role of hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: anti-angiogenic implications in pancreatic cancer', Southampton, Pancreatology 14(3):S9, presented at
, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'IS SECOND LINE CHEMOTHERAPY IN PANCREATIC CANCER ONE LINE TOO MANY?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 150 - 150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'PANCREATIC CANCER PATIENT'S MODERATE OR HIGH UNMET SUPPORTIVE CARE NEEDS OVER TIME AND RISK FACTORS OF FUTURE UNMET NEEDS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 105 - 105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Therapeutic Potential of Angiogenesis Inhibitors for Gastric Cancer', in Annals of Oncology, pp. ix8, http://dx.doi.org/10.1093/annonc/mdt437.1
, 2013, 'Hepatocyte Growth Factor Inhibition: A Therapeutic Approach Superior to Gemcitabine in Pancreatic Cancer?', in Pancreas, Lippincott Williams & Wilkins, Miami, pp. 1377 - 1377, presented at
, 2013, 'beta III-tubulin is a novel therapeutic target for the treatment of pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 12 - 12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Dose delivery in a phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S614 - S614, presented at
, 2013, 'Evaluation of peripheral neuropathy in a phase Ill trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S613 - S613, presented at
, 2013, 'Positron emission tomography (PET) response from a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients (pts) with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S611 - S611, presented at
, 2013, 'What do patients really mean when they complain of fatigue after treatment? Reliable identification of post cancer fatigue', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S283 - S283, presented at
, 2013, 'CA19-9 decrease at 8 weeks as a predictor of overall survival (OS) in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients with metastatic pancreatic cancer (MPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'Prognostic factors (PFs) of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with metastatic pancreatic cancer (MPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'Should culture affect practice? Prognostic discussions with immigrants', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at
, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at
, 2012, 'THE IMPACT OF PHYSICAL ACTIVITY ON DISEASE-FREE SURVIVAL IN PATIENTS WITH HIGH-RISK STAGE II OR III COLON CANCER: ONE MONTH SCREENING RESULTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 345 - 345, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400386&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, MA, Boston, pp. S322 - S322, presented at
, 2012, 'ATTACHE: A phase III, multicenter, randomized comparison of chemotherapy given prior to and post surgical resection versus chemotherapy given post surgical resection for hepatic metastases from colorectal cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at
, 2012, 'Cancer survivorship outcomes in immigrants.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at
, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at
, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at
, 2012, 'Usefulness of medical oncologists' estimates of survival time in people with advanced cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at
, 2011, 'Heat Shock Proteins 27 and 47 Inhibit Platelet-Derived Growth Factor (PDGF)-Induced Pancreatic Stellate Cell Proliferation: Implication in Pancreatic Cancer Progression', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1365 - 1366, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296398000273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'Asthenia and Fatigue as Potential Biomarkers of Sunitinib Efficacy in Metastatic Renal Cell Carcinoma', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S135 - S135, presented at
, 2011, 'A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S436 - S436, presented at
, 2011, 'Asthenia and Fatigue as Predictors of Sunitinib Efficacy In Gastrointestinal Stromal Tumour (GIST)', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S135 - S136, presented at
, 2011, 'Oxaliplatin-induced Neurotoxicity - Comparing Four Methods of Assessment', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S234 - S234, presented at
, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', in Journal of Gastroenterology and Hepatology, Wiley, pp. 20 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'Recipient IL28b Polymorphism Is an Important Independent Predictor of Posttransplant Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C', in LIVER TRANSPLANTATION, WILEY-BLACKWELL, SPAIN, Valencia, pp. S96 - S96, presented at
, 2011, 'Validating innovation: A population-based study of gastrointestinal stromal tumors (GIST) to estimate the survival benefit of imatinib.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2011.29.15_suppl.10060
, 2011, 'Heat shock proteins 27 and 47 inhibit platelet-derived growth factor (PDGF)-induced pancreatic stellate cell proliferation: implication in pancreatic cancer progression', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. 19 - 19, presented at
, 2010, 'Role of Pancreatic Stellate Cells in Pancreatic Cancer: The Urokinase Plasminogen Activator System', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1320 - 1320, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'Role of pancreatic stellate cells in pancreatic cancer: the urokinase plasminogen system', in Journal of Gastroenterology and Hepatology, Wiley, pp. A75 - A75, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'Certain subgroups of Weyl groups are split', in Ara P; Brown KA; Lenagan TH; Letzter ES; Stafford JT; Zhang JJ (eds.), NEW TRENDS IN NONCOMMUTATIVE ALGEBRA, AMER MATHEMATICAL SOC, WA, Univ Washington, Seattle, pp. 101 - +, presented at
, 2010, 'Development of a nomogram to predict overall survival in patients with locally advanced or metastatic gastrointestinal stromal tumor receiving first-line treatment with imatinib', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.10054
, 2010, 'Abstract 1655: Mechanism of the synergistic antiproliferative effect of gefitinib and interferon-alpha in sarcoma cell lines', in Cancer Research, American Association for Cancer Research (AACR), pp. 1655 - 1655, http://dx.doi.org/10.1158/1538-7445.am10-1655
, 2010, 'Late fatigue after adjuvant therapy for early breast cancer is largely unrelated to cancer or its treatment: 5 year follow-up of a prospective cohort study', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 53 - 60, presented at
, 2010, 'Unmet needs in Chinese (Mandarin and Cantonese), Greek, and Arabic-speaking cancer survivors in Australia', in Psycho-oncology, John Wiley & Sons, New York, pp. 1810 - 1813
, 2010, 'What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study', in Journal of Clinical Oncology, American Society of Clinical Oncology, United States, pp. 93s
, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A333 - A334, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200303&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Filter by type
https://orcid.org/0000-0001-6142-3291